Editorial: Stimulants: Friend or Foe?

Timothy E Wilens; Tamar Arit Kaminski

doi:10.1016/j.jaac.2019.11.009

Editorial: Stimulants: Friend or Foe?

J Am Acad Child Adolesc Psychiatry. 2020 Jan;59(1):36-37. doi: 10.1016/j.jaac.2019.11.009. Epub 2019 Nov 20.

Authors

Timothy E Wilens¹, Tamar Arit Kaminski²

Affiliations

¹ Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA. Electronic address: TWilens@partners.org.
² Harvard Medical School, Boston, MA.

PMID: 31759095
DOI: 10.1016/j.jaac.2019.11.009

Abstract

Stimulants remain the treatment of choice for attention-deficit/hyperactivity disorder (ADHD), in part owing to their large effect size within the pharmacotherapeutic repertoire for ADHD-in other words, they are highly effective. When used appropriately, they are also quite safe and actually mitigate the misuse of drugs or alcohol. So, why all the fuss?

Publication types

Editorial
Comment

MeSH terms

Attention Deficit Disorder with Hyperactivity*
Central Nervous System Stimulants*
Humans
Prescriptions
Risk Factors
Risk Reduction Behavior

Substances

Central Nervous System Stimulants